PLoS ONE,
Год журнала:
2024,
Номер
19(10), С. e0312147 - e0312147
Опубликована: Окт. 17, 2024
The
T
cell-mediated
delayed-type
hypersensitivity
(DTH)
response
is
critical
for
elucidating
cellular
immune
mechanisms,
especially
the
role
of
memory
cells
upon
antigen
re-exposure.
This
study
aimed
to
investigate
specific
effects
immunosuppressive
drugs
Cyclophosphamide
(CY)
and
Dexamethasone
(DEX)
on
intestinal
immunity
microbiota
in
a
DTH
mouse
model,
contributing
more
nuanced
understanding
their
immunomodulatory
mechanisms.
Biomedicine & Pharmacotherapy,
Год журнала:
2024,
Номер
179, С. 117302 - 117302
Опубликована: Авг. 19, 2024
Inflammatory
bowel
disease
(IBD),
including
Crohn's
and
ulcerative
colitis,
is
a
complex
disorder
with
an
unknown
cause.
However,
the
dysbiosis
of
gut
microbiome
has
been
found
to
play
role
in
IBD
etiology,
exacerbated
immune
responses
defective
intestinal
barrier
integrity.
The
can
also
be
potential
biomarker
for
several
diseases,
IBD.
Currently,
conventional
treatments
targeting
pro-inflammatory
cytokines
pathways
IBD-associated
do
not
yield
effective
results.
Other
therapies
that
directly
target
dysbiotic
outcomes
are
emerging.
We
review
health
its
as
diagnostic,
prognostic,
therapeutic
This
explores
emerging
advancements
microbiome-associated
alterations
IBD,
such
nanoparticle
or
encapsulation
delivery,
fecal
microbiota
transplantation,
nutritional
therapies,
microbiome/probiotic
engineering,
phage
therapy,
mesenchymal
stem
cells
(MSCs),
proteins,
herbal
formulas.
Gastrointestinal Disorders,
Год журнала:
2024,
Номер
6(2), С. 368 - 379
Опубликована: Март 28, 2024
The
enteric
nervous
system
(ENS),
consisting
of
neurons
and
glial
cells,
is
situated
along
the
gastrointestinal
(GI)
tract’s
wall
plays
a
crucial
role
in
coordinating
digestive
processes.
Recent
research
suggests
that
optimal
functioning
GI
relies
on
intricate
connections
between
ENS,
intestinal
epithelium,
immune
system,
microbiome,
central
(CNS).
Inflammatory
bowel
disease
(IBD)
encompasses
group
chronic
inflammatory
disorders,
such
as
Crohn’s
(CD)
ulcerative
colitis
(UC),
characterized
by
recurring
inflammation
damage
to
tract.
This
review
explores
emerging
dynamic
field
IBD
sheds
light
potential
ENS
alterations
both
etiology
management
IBD.
Specifically,
we
delve
into
IBD-induced
cell
(EGC)
activation
its
implications
for
persistent
gliosis,
elucidating
how
this
disrupts
function
through
gut–brain
axis
(GBA).
Additionally,
examine
IBD-associated
alterations,
focusing
EGC
senescence
acquisition
senescence-associated
secretory
phenotype
(SASP).
We
highlight
pivotal
these
changes
recurrence
Finally,
discuss
therapeutic
interventions
involving
senotherapeutic
agents,
providing
insights
avenues
managing
targeting
ENS-related
mechanisms.
approach
might
represent
alternative
advance
treatment
multifaceted
disease.
Journal of Experimental & Clinical Cancer Research,
Год журнала:
2025,
Номер
44(1)
Опубликована: Март 5, 2025
Neuroendocrine
neoplasms
(NENs)
comprise
a
group
of
rare
tumors
originating
from
neuroendocrine
cells,
which
are
present
in
both
endocrine
glands
and
scattered
throughout
the
body.
Due
to
their
scarcity
absence
specific
markers,
diagnosing
NENs
remains
complex
challenge.
Therefore,
new
biomarkers
required,
ideally,
easy-to-obtain
blood
samples.
A
panel
soluble
immune
checkpoints
(sPD-L1,
sPD-L2,
sPD-1,
sCD25,
sTIM3,
sLAG3,
Galectin-9,
sCD27,
sB7.2
sSIGLEC5)
cytokines
(IL4,
IL6,
IP10
MCP1)
was
quantified
cohort
139
NENs,
including
29
pituitary
46
pheochromocytomas
paragangliomas,
67
gastroenteropancreatic
pulmonary
(GEPP)
as
well
64
healthy
volunteers
(HVs).
The
potential
these
circulating
immunological
parameters
distinguish
HVs,
differentiate
among
various
subtypes,
predict
prognosis
evaluated
using
mathematical
regression
models.
These
factors-based
models
generated
scores
that
were
by
Receiver
Operating
Characteristic
(ROC)
Area
Under
Curve
(AUC)
analyses.
Correlations
between
clinical
data
performed.
From
analyses,
minimal
signature
emerged,
comprising
five
shared
factors
across
models:
Galectin-9.
This
refined
evaluated,
validated,
checked
for
specificity
against
non-neuroendocrine
tumors,
demonstrating
its
clinically
relevant
tool
identifying
distinct
NENs.
Most
analyzed
showed
expression
patterns
different
Scores
based
on
signatures
identified
with
high
efficiency,
showing
AUCs
ranging
0.948
0.993
depending
comparison,
accuracies
92.52%
95.74%.
illustrated
biological
features
similarity
divergence
gastrointestinal
correlated
features.
Furthermore,
demonstrated
strong
performance
distinguishing
metastatic
exitus
GEPP
achieving
sensitivities
specificities
80.95%
88.89%.
Additionally,
an
easy-to-implement
successfully
all
AUC
values
exceeding
0.900,
84.11%
93.12%,
internally
validated
discovery
validation
randomization
strategy.
findings
highlight
effectiveness
accurately
differentiating
analysis
presents
promising
liquid
biopsy
approach
delivering
critical
insights
diagnosis.
study
serves
proof-of-concept
innovative
holds
transform
management
malignancies,
providing
non-invasive
effective
method
early
detection
disease
monitoring.
Antibiotics,
Год журнала:
2025,
Номер
14(4), С. 371 - 371
Опубликована: Апрель 3, 2025
The
human
gut
microbiota—an
intricate
and
dynamic
ecosystem—plays
a
pivotal
role
in
metabolic
regulation,
immune
modulation,
the
maintenance
of
intestinal
barrier
integrity.
Although
antibiotic
therapy
is
indispensable
for
managing
bacterial
infections,
it
profoundly
disrupts
microbial
communities.
Such
dysbiosis
typified
by
diminished
diversity
shifts
community
structure,
especially
among
beneficial
genera
(e.g.,
Bifidobacterium
Eubacterium),
fosters
antibiotic-resistant
strains
horizontal
transfer
resistance
genes.
These
alterations
compromise
colonization
resistance,
increase
permeability,
amplify
susceptibility
to
opportunistic
pathogens
like
Clostridioides
difficile.
Beyond
gastrointestinal
disorders,
emerging
evidence
associates
with
systemic
conditions,
including
chronic
inflammation,
syndrome,
neurodegenerative
diseases,
underscoring
relevance
microbiota–gut–brain
axis.
recovery
pre-existing
communities
post-antibiotic
highly
variable,
influenced
drug
spectrum,
dosage,
treatment
duration.
Innovative
interventions—such
as
fecal
microbiota
transplantation
(FMT),
probiotics,
synbiotics,
precision
microbiome
therapeutics—have
shown
promise
counteracting
mitigating
its
adverse
effects.
therapies
align
closely
stewardship
programs
aimed
at
minimizing
unnecessary
use
preserve
curtail
spread
multidrug-resistant
organisms.
This
review
emphasizes
pressing
need
microbiota-centered
strategies
optimize
administration,
promote
long-term
health
resilience,
alleviate
disease
burden
associated
antibiotic-induced
dysbiosis.
Precision Clinical Medicine,
Год журнала:
2024,
Номер
7(3)
Опубликована: Июль 24, 2024
Abstract
Inflammatory
bowel
disease
(IBD)
is
a
chronic
inflammatory
disorder
of
the
gastrointestinal
tract,
and
its
pathogenesis
believed
to
be
associated
with
an
imbalance
between
commensal
organisms
intestinal
immune
system.
This
significantly
influenced
by
microbiota
metabolites
plays
critical
role
in
maintaining
mucosal
homeostasis.
However,
disturbances
cause
dysregulated
responses
consequently
induce
inflammation.
Recent
studies
have
illustrated
roles
IBD
underscored
potential
precision
diagnosis
therapy.
work
summarises
recent
progress
this
field
particularly
focuses
on
application
diagnosis,
prognosis
assessment,
treatment
effectiveness
evaluation,
therapeutic
management
IBD.
Critical Reviews in Food Science and Nutrition,
Год журнала:
2025,
Номер
unknown, С. 1 - 23
Опубликована: Март 6, 2025
Studies
have
indicated
that
milk
extracellular
vesicles
(EVs)
are
resistant
to
both
the
enzymatic
activity
of
digestive
enzymes
and
acidic
conditions
common
in
gastrointestinal
tract.
Thus,
intestinal
tract
efficiently
absorbs
uses
these
EVs.
There
is
mounting
evidence
recent
years
microRNAs
(miRNAs)
found
EVs
derived
from
essential
for
prebiotic
effect
through
target
gene
regulation.
In
this
paper,
we
summarized
sources,
biosynthetic
processes,
cargos,
factors
affecting
milk-derived
Furthermore,
with
particular
attention
potential
communication
mechanism
cell
receptors,
including
recognizing
binding
surface
receptor
cells,
internalization
uptake,
cargos
acting
on
cells.
Especially,
also
explored
role
several
aspects
health,
such
as
immunological
homeostasis,
barrier,
injury,
inflammatory
bowel
disease,
necrotizing
enterocolitis,
malignancy,
harm
other
organs
connected
intestine.
We
expected
use
or
miRNAs
new
dietary
additives
functional
regulatory
factors.
future,
will
gain
more
knowledge
about
substantial
impact
human
intestines
health-related
matters.
Patients
affected
by
inflammatory
bowel
diseases
(IBD)
can
nowadays
benefit
from
a
growing
number
of
pharmacological
options.
However,
in
moderate-to-severe
cases,
the
therapeutic
response
is
still
far
optimal,
and
treatment
changes
optimizations
are
often
required.
Thus,
researchers
this
field
strongly
engaged
studies
aiming
to
identify
new
potential
targets.
Extracellular
vesicles
(EVs)
tiny
subcellular
bodies
with
phospholipid
bilayer
envelope
containing
bioactive
molecules,
which
released
different
cells
involved
intercellular
communication.
Recent
pre-clinical
data
show
their
emerging
role
pathogenesis
IBD.
In
our
review,
we
summarize
current
evidence
about
function
EVs
as
active
agents
ulcerative
colitis
Crohn’s
disease,
analyzing
properties
derived
cellular
sources
mechanisms
through
they
may
improve
intestinal
inflammation.